Brazil’s health regulator authorizes emergency use of medicine against Covid-19
The drug was authorized for use in patients with mild to moderate disease and at risk of developing into a...
September 8, 2021
The drug was authorized for use in patients with mild to moderate disease and at risk of developing into a...
September 8, 2021
RIO DE JANEIRO, BRAZIL - The National Health Regulatory Agency (Anvisa) received, on Monday (19), a request for emergency use...
July 19, 2021